Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-   A3826 SMIP004Summary: Apoptosis inducer A3826 SMIP004Summary: Apoptosis inducer
-   A4459 Bax channel blockerSummary: Inhibitor of Bax-mediated mitochondrial cytochrome c release A4459 Bax channel blockerSummary: Inhibitor of Bax-mediated mitochondrial cytochrome c release
-   C3129 R-7050Summary: TNF-α receptor signaling antagonist,cell-permeable C3129 R-7050Summary: TNF-α receptor signaling antagonist,cell-permeable
-   B4984 MI-77301 (SAR405838)Summary: orally available MDM2 antagonist B4984 MI-77301 (SAR405838)Summary: orally available MDM2 antagonist
-   A4208 NSC 319726Target: p53Summary: Reactivator of mutant p53 A4208 NSC 319726Target: p53Summary: Reactivator of mutant p53
-   A1925 Caspase-3/7 Inhibitor I2 CitationTarget: CaspasesSummary: Caspase-3/7 inhibitor A1925 Caspase-3/7 Inhibitor I2 CitationTarget: CaspasesSummary: Caspase-3/7 inhibitor
-   A3746 R1530Summary: Antiangiogenesis,mitosis-angiogenesis inhibitor (MAI) A3746 R1530Summary: Antiangiogenesis,mitosis-angiogenesis inhibitor (MAI)
-   B6194 GSK481Summary: RIP1(Receptor Interacting Protein Kinase 1) inhibitor B6194 GSK481Summary: RIP1(Receptor Interacting Protein Kinase 1) inhibitor
-   B4813 Pifithrin-βSummary: potent p53 inhibitor B4813 Pifithrin-βSummary: potent p53 inhibitor
-   A4206 Pifithrin-α (PFTα)6 CitationTarget: p53Summary: p53 inhibitor A4206 Pifithrin-α (PFTα)6 CitationTarget: p53Summary: p53 inhibitor

